PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNews'Big data on steroids': IBM's Watson supercomputer to work on brain cancer genetics

BioNews

'Big data on steroids': IBM's Watson supercomputer to work on brain cancer genetics

Published 24 March 2014 posted in News and appears in BioNews 747

Author

Chris Baldacci

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

IBM and the New York Genome Centre have teamed up to announce the latest weapon in the fight against cancer - Watson the supercomputer....

IBM and the New York Genome Centre have teamed up to announce the latest weapon in the fight against cancer - Watson, the supercomputer.

Researchers will use a prototype of IBM's cloud computing system specifically adapted for genomic research to read and interpret vast amounts of genetic data to help tailor treatment for a common type of brain cancer.

The project is starting with 25 patients affected by glioblastoma multiforme, an aggressive and malignant brain cancer that is usually fatal within a few months. However, it usually takes longer than this to sequence a patient and their tumour's respective genomes and then to use this information to discover the best targets for treatment. Watson is expected to reduce the time it takes to correlate a patient's genetic data with other relevant literature.

Dr Robert Darnell, New York Genome Center's president and scientific director, explains that analysing a patient's brain tumour involves sequencing around 800 billion DNA base pairs. The DNA data must then be combined with a patient's clinical data, medical literature, study findings and other relevant material to enable doctors to consider which of a variety of treatment options are best suited to a patient.

Once researchers have sequenced the patient's genome and that of the tumour using rapid genome sequencing, they feed all the data into Watson. Because the system uses artificial intelligence, it can 'learn' what proteins are produced by the cancer by scouring through huge volumes of clinical research for an answer and then apply this knowledge to subsequent problems or treatment strategies.

'As genomic research progresses and information becomes more available, we aim to make the process of analysis much more practical and accessible through cloud-based, cognitive innovations like Watson', said Dr John Kelly, research director at IBM. He told BBC News: 'It's like big data on steroids'.

'Watson can do in seconds what would take people years. And we can get it down to a really personal level. This is the proverbial needle in the haystack and the haystack is enormous'.

Sources and References

  • 19/03/2014
    New York Genome Center (press release)
    The New York Genome Center and IBM Watson Group Announce Collaboration to Advance Genomic Medicine
  • 20/03/2014
    BBC News
    IBM's supercomputer Watson to help fight brain cancer
  • 19/03/2014
    Forbes
    IBM's Watson Attempts To Tackle The Genetics Of Brain Cancer
  • 19/03/2014
    SF Gate (Associated Press)
    IBM's Watson computer joining brain cancer battle

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
31 July 2017 • 2 minutes read

Supercomputer overcomes key cancer genomics bottleneck

by Rikita Patel

The IBM Watson supercomputer can analyse 160 hours' worth of genomic data in just ten minutes...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 January 2014 • 3 minutes read

Illumina claims the $1,000 genome crown

by Dr Rachael Panizzo

The $1,000 genome may have arrived, an achievement which would mark a significant milestone in the application of genetic science...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 January 2014 • 2 minutes read

New York State launches genomic medicine project with $105 million

by Daryl Ramai

The New York State Governor, Andrew Cuomo, has announced a US$105 million partnership between the New York Genome Center (NYGC) and the University of Buffalo (UB) to accelerate genomic research in the region....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 October 2013 • 2 minutes read

David Cameron announces cancer genome sequencing collaboration

by Rhys Baker

The Prime Minister, David Cameron, has announced a new partnership between Genomics England and Cancer Research UK as part of a Government bid to make the UK the first country in the world to sequence 100,000 genomes within five years....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 July 2013 • 2 minutes read

Largest ever cancer gene database open to all researchers

by Maren Urner

The world's largest database of cancer-related genetic variations to date has been made available by the National Cancer Institute (NCI), US...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Miscarriage more likely when fewer eggs produced

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels


easyfundraising
amazon

This month in News

  • Popular
  • Recent
20 November 2023 • 3 minutes read

HFEA publishes recommendations for reform of fertility law

13 November 2023 • 2 minutes read

Four BRCA mutation carriers undergo removal of ovaries during C-section 

13 November 2023 • 2 minutes read

Frequent mobile phone use linked to lower sperm count in young men

6 November 2023 • 3 minutes read

Health Council of the Netherlands recommends doubling the 14-day limit on embryo research

30 October 2023 • 2 minutes read

Government to scrap additional IVF screening for same-sex couples

27 November 2023 • 2 minutes read

Research into gene therapy reveals blood cancer risk

27 November 2023 • 2 minutes read

Polish Parliament debates reinstatement of state IVF funding

27 November 2023 • 2 minutes read

Over 100,000 DNA evidence samples must be re-tested in Australia

27 November 2023 • 2 minutes read

Childhood autism associated with infertility in parents

27 November 2023 • 2 minutes read

Unintended consequence of CRISPR/Cas9 genome editing discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856